Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 17.50M | 74.12M | 72.11M | 69.39M | 15.15M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.50M | 74.12M | 72.11M | 69.39M | 15.15M |
| Cost of Revenue | 1.21M | 56.29M | 43.28M | 41.03M | 2.57M |
| Gross Profit | 16.29M | 17.84M | 28.83M | 28.36M | 12.58M |
| SG&A Expenses | 19.04M | 49.57M | 23.54M | 23.61M | 16.26M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -3.28M | -1.44M | -903.00K | 93.00K | -707.00K |
| Total Operating Expenses | 16.97M | 104.42M | 65.92M | 64.73M | 18.12M |
| Operating Income | 524.00K | -30.30M | 6.20M | 4.66M | -2.97M |
| Income Before Tax | 10.49M | 37.04M | 41.35M | 54.26M | 8.29M |
| Income Tax Expenses | 4.36M | 6.28M | 6.89M | 43.00K | 5.35M |
| Earnings from Continuing Operations | 6.14M | 30.76M | 34.46M | 54.21M | 2.94M |
| Earnings from Discontinued Operations | 46.66M | -- | -- | -- | 7.25M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 52.80M | 30.76M | 34.46M | 54.21M | 10.19M |
| EBIT | 524.00K | -30.30M | 6.20M | 4.66M | -2.97M |
| EBITDA | 2.03M | -20.43M | 10.12M | 8.56M | -1.25M |
| EPS Basic | 0.09 | 0.07 | 0.07 | 0.12 | 0.03 |
| Normalized Basic EPS | 0.01 | 0.02 | 0.05 | 0.08 | 0.02 |
| EPS Diluted | 0.09 | 0.07 | 0.07 | 0.12 | 0.03 |
| Normalized Diluted EPS | 0.01 | 0.02 | 0.05 | 0.08 | 0.02 |
| Average Basic Shares Outstanding | 613.50M | 439.41M | 492.24M | 451.78M | 339.57M |
| Average Diluted Shares Outstanding | 613.50M | 439.41M | 492.24M | 451.78M | 339.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |